Search results
Harsco Corporation (NYSE:HSC) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoHarsco Corporation (NYSE:HSC) Q4 2022 Earnings Call Transcript February 27, 2023 Operator: Good...
Harsco First Quarter 2023 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 year agoHarsco (NYSE:HSC) First Quarter 2023 Results Key Financial Results Revenue: US$495.7m (up 9.5% from...
Earnings Preview: Harsco (HSC) Q3 Earnings Expected to Decline
Zacks via Yahoo Finance· 2 years agoHarsco (HSC) doesn't possess the right combination of the two key ingredients for a likely earnings...
Harsco (HSC) Beats Q3 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 2 years agoHarsco (HSC) delivered earnings and revenue surprises of 242.86% and 5.54%, respectively, for the quarter ended September 2022. Do the numbers hold clues...
Harsco Corporation's (NYSE:HSC) Intrinsic Value Is Potentially 22% Below Its Share Price
Simply Wall St. via Yahoo Finance· 2 years agoHow far off is Harsco Corporation (NYSE:HSC) from its intrinsic value? Using the most recent...
Investors three-year losses continue as Harsco (NYSE:HSC) dips a further 9.4% this week, earnings...
Simply Wall St. via Yahoo Finance· 2 years agoIt's not possible to invest over long periods without making some bad investments. But you want to...
Orchard Therapeutics plc (NASDAQ:ORTX) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoOrchard Therapeutics plc (NASDAQ:ORTX) Q4 2022 Earnings Call Transcript March 10, 2023 Bobby Gaspar...
Why Harsco Stock Rallied as Much as 20% in Early Trading Today
Motley Fool· 2 years agoWhat happened Shares of Harsco (NYSE: HSC), an environmental solutions company, rose dramatically on...
Editas Medicine Inc (EDIT) Q3 2023 Earnings: Net Loss Narrows to $45. ...
GuruFocus.com via Yahoo Finance· 6 months agoEditas Medicine Inc (NASDAQ:EDIT) reports a net loss of $45.0 million for Q3 2023, down from $55.7...
Avrobio's Pompe Disease Gene Therapy Shows Efficacy, Safety In Preclinical Study
Benzinga via Yahoo Finance· 2 years agoAvrobio Inc (NASDAQ: AVRO) announced preclinical data demonstrating the efficacy and safety of...